다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Brazilian journal of pharmaceutical sciences : BJPS, v.48 no.3, 2012년, pp.369 - 377
Yamada, André (Federal University of Sã) , Katayama (o Carlos) , Verlengia, Rozangela (University Methodist of Piracicaba) , Bueno Junior, Carlos Roberto (University of Sã)
AI-Helper
Since its discovery, myostatin (MSTN) has been at the forefront of muscle therapy research because intrinsic mutations or inhibition of this protein, by either pharmacological or genetic means, result in muscle hypertrophy and hyperplasia. In addition to muscle growth, MSTN inhibition potentially di...
J. Biotechnol. ACOSTA J. 119 324 2005 10.1016/j.jbiotec.2005.04.023 Myostatin gene silenced by RNAi show a zebrafish giant phenotype
Mol. Ther. BAOUTINA A. 15 1751 2007 10.1038/sj.mt.6300278 Potential use of gene transfer in athletic performance enhancement
Hum. Gene. Ther. BISH L.T. 22 1499 2011 10.1089/hum.2011.102 Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy
Bioanalysis BOGANI P. 3 2523 2011 10.4155/bio.11.260 Transgene traceability in transgenic mice: a bioanalytical approach for potential gene-doping
0028-0836 Nature BOGDANOVICH S. 420 418 2002 10.1038/nature01154 Functional improvement of dystrophic muscle by myostatin blockade
0022-0302 J. Dairy Sci. BUSKE B. 94 3687 2011 10.3168/jds.2010-4057 Short-communication: influence of the muscle hypertrophy mutation of the myostatin gene on milk production traits and milk fatty acid composition in dual-purpose Belgian Blue dairy cattle
Muscle BUSQUETS S. 3 37 2012 Myostatin blockage using actRIIB antagonism in mice bearing in Lewis lung carcinoma results in the improvement of muscle wasting and physical performance. J. Cachex. Sarcopenia
J. Appl. Physiol. CANDENA S.M. 109 635 2010 10.1152/japplphysiol.00866.2009 Administration of a soluble activin type II B receptor promotes skeletal muscle growth independent of fiber type
Eur. J. Appl. Physiol. CARTER A. 112 1527 2012 10.1007/s00421-011-2113-y A polymerase chain reaction-based methodology to detect gene doping
Annu. Rev. Med. CAVAZZANA-CALVO M. 56 585 2005 10.1146/annurev.med.56.090203.104142 Gene therapy for severe combined immunodeficiency
J. Anatom. ELASHRY M.I. 220 603 2012 10.1111/j.1469-7580.2012.01503.x Characterization of connective tissue from the hypertrophic skeletal muscle of myostatin null mice
0270-7306 Mol. Cell. Biol. FOURNIER B. 32 2871 2012 10.1128/MCB.06575-11 Blockade of the activin receptor IIB activates functional brown adipogenesis and thermogenesis by inducing mitochondrial oxidative metabolism
Pediatr. Clin. North Am. GAFFNEY G.R. 54 807 2007 10.1016/j.pcl.2007.04.004 Gene doping: a review of performance-enhancing genetics
Expert Opin. Biol. Ther. GAMBARI R. 12 443 2012 10.1517/14712598.2012.665047 Alternative options for DNA-based experimental therapy of β-thalassemia
Am. J. Physiol. Endocrinol. Metab. GILSON H. 297 E157 2009 10.1152/ajpendo.00193.2009 Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin
Curr. Gene Ther. GREGORY-EVANS K. 12 103 2012 10.2174/156652312800099607 Ex vivo gene therapy and vision
0027-8424 Proc. Natl. Acad. Sci. HAIDET A.M. 105 4318 2008 10.1073/pnas.0709144105 Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
Curr. Opin. Support Palliat. Care HAN H.Q. 5 334 2011 10.1097/SPC.0b013e32834bddf9 Targeting the myostatin signaling pathway to treat muscle wasting diseases
0009-7322 Circulation HEINEKE J. 121 419 2010 10.1161/CIRCULATIONAHA.109.882068 Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
PloS One HILL E.W. 5 e8645 2010 10.1371/journal.pone.0008645 A sequence polymorphism in MSTN predicts sprinting ability and racing stamina in thoroughbred horses
Mol. Ther. KANG J.K. 19 159 2011 10.1038/mt.2010.212 Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa-guanodine morpholino oligomer treatment
Drug. Test. Anal. KOHLER M. 3 661 2011 10.1002/dta.330 RNA interference for performance enhancement and detection in doping control
Nat. Rev. Drug Discov. KOLE R. 11 125 2012 10.1038/nrd3625 RNA therapeutics: beyond RNA interference and antisense oligonucleotides
0013-7227 Endocrinology KONCAREVIC A. 153 3133 2012 10.1210/en.2012-1016 A novel therapeutic approach to treating obesity through modulation of TGFβ signaling
Sci. Transl. Med. KOTA J. 1 6 6ra15 2009 10.1126/scitranslmed.3000112 Follistatin gene delivery enhances muscle growth and strength in nonhuman primates
0148-639X Muscle Nerve KRIVICKAS L.S. 39 2 2009 10.1002/mus.21200 Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029
J. Gerontol. A. Biol. Sci. Med. Sci. LEBRASSEUR N.K. 64 940 2009 10.1093/gerona/glp068 Myostatin inhibition enhances the effect of exercise on performance and metabolic outcomes in aged mice
Skeletal Muscle LEE S.J. 1 2011 Treating cancer cachexia to treat cancer
Immunol. Endocr. Metab. Agents Med. Chem. LEE S.J. 10 183 2010 10.2174/187152210793663748 Extracellular regulation of myostatin: a molecular rheostat for muscle mass
Mol. Endocrinol. LEE S.J. 24 1998 2010 10.1210/me.2010-0127 Regulation of muscle mass by follistatin and activins
0027-8424 Proc. Natl. Acad. Sci. LEE S.J. 102 18117 2005 10.1073/pnas.0505996102 Regulation of muscle growth by multiple ligands signaling through activin type II receptors
J. Cachex. Sarcopenia Muscle LENK K. 1 9 2010 10.1007/s13539-010-0007-1 Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
Drug Test Anal. MANSOUR M.M. 1 311 2009 10.1002/dta.52 The hunt for gene dopers
Exp. Physiol. MATSAKAS A. 97 125 2012 10.1113/expphysiol.2011.063008 Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in myostatin null mouse
J. Cell. Biol. MCCROSKERY S. 162 1135 2003 10.1083/jcb.200207056 Myostatin negatively regulates satellite cell activation and self-renewal
Ped. Clin. North Am. MCFARLANE C. 57 719 2010 10.1016/j.pcl.2010.02.006 Gene doping: the hype and the harm
0027-8424 Proc. Natl. Acad. Sci. MCPHERRON A.C. 9423 12457 1997 10.1073/pnas.94.23.12457 Double muscling in cattle due to mutations in the myostatin gene
0028-0836 Nature MCPHERRON A.C. 387 83 1997 10.1038/387083a0 Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
PLoS One MORINE K.J. 5 e9176 2010 10.1371/journal.pone.0009176 Systemic myostatin inhibition via liver-targeted gene transfer in normal and distrophic mice
PLoS Genet. MOSHER D.S. 3 e79 2007 10.1371/journal.pgen.0030079 A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs
FASEB J. MURPHY K.T. 24 4433 2010 10.1096/fj.10-159608 Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function
Braz. J. Med. Biol Res. OLIVEIRA R.S. 44 1194 2011 10.1590/S0100-879X2011007500145 The use of genes for performance enhancement: doping or therapy?
Physiol. Genomics. RAHIMOV F. 43 398 2011 10.1152/physiolgenomics.00223.2010 Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
Mol. Genet. Metab. RAPER S. 80 248 2003 10.1016/j.ymgme.2003.08.016 Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenovirus gene transfer
0148-639X Muscle Nerve RODINO-KAPLAC L.R. 39 283 2009 10.1002/mus.21244 Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
PloS One SANTIAGO C. 6 e16323 2011 10.1371/journal.pone.0016323 The K153R polymorphism in the myostatin gene and muscle power phenotypes in young, non-athletic men
0003-2700 Anal. Chem. SCARANO S. 83 6245 2011 10.1021/ac200877m Simultaneous detection of transgenic DNA by surface plasmon resonance imaging with potential application to gene doping detection
0028-4793 N. Engl. J. Med. SCHUELKE M. 350 2682 2004 10.1056/NEJMoa040933 Myostatin mutation associated with gross muscle hypertrophy in a child
Am. J. Physiol. Cell Physiol. SHARMA M. 301 C195 2011 10.1152/ajpcell.00012.2011 Human myostatin negatively regulates human myoblast growth and differentiation
Circ. Res. TILEMANN L. 110 777 2012 10.1161/CIRCRESAHA.111.252981 Gene therapy for heart failure
Ann. Neurol. WAGNER K.R. 63 561 2008 10.1002/ana.21338 A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy
J. Physiol. WANG Q. 590 2151 2012 10.1113/jphysiol.2011.226001 Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation
Am. J. Physiol. Endocrinol. Metab. WELLE S. 300 E993 2011 10.1152/ajpendo.00509.2010 Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism
Mol. Ther. ZHANG Y. 20 7 1298 2012 10.1038/mt.2012.79 In vivo gene delivery by nonviral vectors: overcoming hurdles?
0036-8075 Science ZIMMERS T.A. 29 1486 2002 10.1126/science.1069525 Induction of cachexia in mice by systemically administered myostatin
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.